To study the effect of two Ayurveda medicines in patients with excessive menstrual bleeding

A comparative clinical study of Shonitasthapana Mahakashaya and Bolabaddha Rasa in the management of Asrigdara with special reference to dysfunctional uterine bleeding

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013081

Enrollment

100

Registered

2018-04-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dysfunctional uterine bleeding

Interventions

Intervention1: Shonitasthapana mahakashaya Ghana: 500 mg BD orally with Madhu as sahapana for 60 days Control Intervention1: Bolabaddha rasa: 500 mg BD orally with Madhu as Sahapana for 60 days

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of Asrigdara as a cardinal symptom. 1.Heavy menstrual bleeding (amount >80ml) or 2.Prolonged menstrual bleeding (duration >7 days) or 3.Inter menstrual bleeding or 4.Frequent menstrual cycle (interval

Exclusion criteria

Exclusion criteria: 1.Pregnant women. 2.Patients having bleeding due to abortion. 3.Patients having bleeding after menopause. 4.Patients having coagulation disorders. 5.Any type of malignancy. 6.Patients having STIs. 7.Patients having systemic diseases. 8.Patients having bleeding due to uterine or pelvic pathology 9.Patients using IUCD.

Design outcomes

Primary

Measure	Time frame
Improvement in symptoms and signs of dysfunctional uterine bleedingTimepoint: 3 months	—

Secondary

Measure	Time frame
Restoration of normal menstrual cycle i.e amount and intervalTimepoint: 6 months	—

Countries

India

Contacts

Public ContactProf Sushila Sharma

National institute of ayurveda

sushila.sharma.s@gmail.com9660843984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026